CpG-2216

N/A

Report date: 2023/02/04 20:21:18

Base Information

Drug NameCpG-2216
Drug Alias NameCpG-ODN-2216
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionImmunomodulatorsImmunostimulantsToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColey Pharmaceutical Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColey Pharmaceutical Group Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A